1,552
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Long-term follow-up of osteoradionecrosis of the mandible

, , , &
Pages 48-54 | Received 01 Mar 2023, Accepted 05 Sep 2023, Published online: 29 Sep 2023

References

  • Stoyanov GS, Kitanova M, Dzhenkov DL, et al. Demographics of head and neck cancer patients: a single institution experience. Cureus. 2017;9(7):e1418. doi: 10.7759/cureus.1418.
  • Lin A. Radiation therapy for oral cavity and oropharyngeal cancers. Dent Clin North Am. 2018;62(1):99–109. doi: 10.1016/j.cden.2017.08.007.
  • Huang SH, O’Sullivan B. Oral cancer: current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal. 2013;18(2):e233–e240. doi: 10.4317/medoral.18772.
  • More Y, D’Cruz AK. Oral cancer: review of current management strategies. Natl Med J India. 2013;26(3):152–158.
  • Tirelli G, Boscolo Nata F, Piovesana M, et al. Transoral surgery (TOS) in oropharyngeal cancer: different tools, a single mini-invasive philosophy. Surg Oncol. 2018;27(4):643–649. doi: 10.1016/j.suronc.2018.08.003.
  • Gobillot TA, Kaka AS, Patel SA, et al. Treatment of tonsillar carcinoma following nononcologic tonsillectomy: efficacy of transoral robotic revision tonsillectomy. Otolaryngol Head Neck Surg. 2019;160(4):627–634. doi: 10.1177/0194599818802185.
  • Baliga S, Kabarriti R, Jiang J, et al. Utilization of transoral robotic surgery (TORS) in patients with oropharyngeal squamous cell carcinoma and its impact on survival and use of chemotherapy. Oral Oncol. 2018;86:75–80. doi: 10.1016/j.oraloncology.2018.06.009.
  • Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983;41(6):351–357. doi: 10.1016/s0278-2391(83)80005-6.
  • Kumar S, Chandran C, Chacko R, et al. Osteoradionecrosis of jaw: an institutional experience. Contemp Clin Dent. 2018;9(2):242–248. doi: 10.4103/ccd.ccd_843_17.
  • Perrier M, Moeller P. Osteoradionecrosis: a review of the literature. Schweiz Monatsschr Zahnmed. 1994;104(3):271–277.
  • Dai T, Tian Z, Wang Z, et al. Surgical management of osteoradionecrosis of the jaws. J Craniofac Surg. 2015;26(2):e175–e179. doi: 10.1097/SCS.0000000000001445.
  • Reuther T, Schuster T, Mende U, et al. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour ­patients–a report of a thirty year retrospective review. Int J Oral Maxillofac Surg. 2003;32(3):289–295. doi: 10.1054/ijom.2002.0332.
  • Manzano BR, Santaella NG, Oliveira MA, et al. Retrospective study of osteoradionecrosis in the jaws of patients with head and neck cancer. J Korean Assoc Oral Maxillofac Surg. 2019;45(1):21–28. doi: 10.5125/jkaoms.2019.45.1.21.
  • Marwan H, Green JM3rd, Tursun R, et al. Recurrent malignancy in osteoradionecrosis specimen. J Oral Maxillofac Surg. 2016;74(11):2312–2316. doi: 10.1016/j.joms.2016.04.028.
  • Chronopoulos A, Zarra T, Ehrenfeld M, et al. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J. 2018;68(1):22–30. doi: 10.1111/idj.12318.
  • Vissink A, Jansma J, Spijkervet FK, et al. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199–212. doi: 10.1177/154411130301400305.
  • Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74. doi: 10.1016/0891-4222(94)00028-8.
  • Deshpande SS, Thakur MH, Dholam K, et al. Osteoradionecrosis of the mandible: through a radiologist’s eyes. Clin Radiol. 2015;70(2):197–205. doi: 10.1016/j.crad.2014.09.012.
  • Ben-David MA, Diamante M, Radawski JD, et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007;68(2):396–402. doi: 10.1016/j.ijrobp.2006.11.059.
  • Epstein J, van der Meij E, McKenzie M, et al. Postradiation osteonecrosis of the mandible: a long-term follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol. 1997;83(6):657–662. doi: 10.1016/s1079-2104(97)90314-0.
  • Murray CG, Herson J, Daly TE, et al. Radiation necrosis of the mandible: a 10-year study. Part I. Factors influencing the onset of necrosis. Int J Radiat Oncol Biol Phys. 1980;6(5):543–548. doi: 10.1016/0360-3016(80)90380-6.
  • Studer G, Gratz KW, Glanzmann C. Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol. 2004;180(4):233–240. doi: 10.1007/s00066-004-1171-z.
  • Aarup-Kristensen S, Hansen CR, Forner L, et al. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019;58(10):1373–1377. doi: 10.1080/0284186X.2019.1643037.
  • Maesschalck T, Dulguerov N, Caparrotti F, et al. Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy. Head Neck. 2016;38(11):1695–1702. doi: 10.1002/hed.24505.
  • Willaert R, Nevens D, Laenen A, et al. Does intensity-modulated radiation therapy lower the risk of osteoradionecrosis of the jaw? A long-term comparative analysis. Int J Oral Maxillofac Surg. 2019;48(11):1387–1393. doi: 10.1016/j.ijom.2019.04.018.
  • Tsai CJ, Hofstede TM, Sturgis EM, et al. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2013;85(2):415–420. doi: 10.1016/j.ijrobp.2012.05.032.
  • Hammerlid E. From 2008–2012. Available from: https://cancercentrum.se/globalassets/cancerdiagnoser/huvud-och-hals/kvalitetsregister/presentation-in-english-swehncr.pdf.
  • Schwartz HC, Kagan AR. Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am J Clin Oncol. 2002;25(2):168–171. doi: 10.1097/00000421-200204000-00013.
  • Breslow NE, Day NE. Statistical methods in cancer research. IARC Sci Publ. 1987;(82):1–406.
  • Albertsson-Wikland K, Mårtensson A, Sävendahl L, et al. Mortality Is not increased in recombinant human growth hormone-treated patients when adjusting for birth characteristics. J Clin Endocrinol Metab. 2016;101(5):2149–2159. doi: 10.1210/jc.2015-3951.
  • Chronopoulos A, Zarra T, Tröltzsch M, et al. Osteoradionecrosis of the mandible: a ten year single-center retrospective study. J Craniomaxillofac Surg. 2015;43(6):837–846. doi: 10.1016/j.jcms.2015.03.024.
  • Leslie H, Sobin CW, Gospodarowicz MK. TNM classification of malignant tumours. 7 ed. New York: Wiley-Blackwell; 2011.
  • Gomez DR, Estilo CL, Wolden SL, et al. Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;81(4):e207–e213. doi: 10.1016/j.ijrobp.2011.02.003.
  • Studer G, Graetz KW, Glanzmann C. In response to dr. Merav A. Ben-David et al. (“Lack of osteoradionecrosis of the mandible after IMRT,” Int J Radiat Oncol Biol Phys 2007: In Press). Int J Radiat Oncol Biol Phys. 2007;68(5):1583–1584. doi: 10.1016/j.ijrobp.2007.04.030.
  • Mohamed AS, Hobbs BP, Hutcheson KA. Dose-volume correlates of mandibular osteoradionecrosis in oropharynx cancer patients receiving intensity-modulated radiotherapy: results from a case-matched comparison. Radiother Oncol. 2017;124(2):232–239.
  • Owosho AA, Tsai CJ, Lee RS, et al. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): the memorial sloan kettering cancer center experience. Oral Oncol. 2017;64:44–51. doi: 10.1016/j.oraloncology.2016.11.015.
  • Davis DD, Hanley ME, Cooper JS. Osteoradionecrosis. Treasure Island (FL): StatPearls Publishing; 2020.
  • Wahl MJ. Osteoradionecrosis prevention myths. Int J Radiat Oncol Biol Phys. 2006;64(3):661–669. doi: 10.1016/j.ijrobp.2005.10.021.
  • Moon DH, Moon SH, Wang K, et al. Incidence of, and risk factors for mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers. Oral Oncol. 2017;72:98–103. doi: 10.1016/j.oraloncology.2017.07.014.
  • Danielsson D, Hagel E, Dybeck-Udd S, et al. Brachytherapy and osteoradionecrosis in patients with base of tongue cancer. Acta Otolaryngol. 2023;143(1):77–84. doi: 10.1080/00016489.2022.2161627.
  • Hussein AA, Helder MN, de Visscher JG, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer. 2017;82:115–127. doi: 10.1016/j.ejca.2017.05.026.
  • Pereira IF, Firmino RT, Meira HC, et al. Osteoradionecrosis prevalence and associated factors: a ten years retrospective study. Med Oral Patol Oral Cir Bucal. 2018;23(6):e633–e638. doi: 10.4317/medoral.22310.
  • Weatherspoon DJ, Chattopadhyay A, Boroumand S, et al. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000–2010. Cancer Epidemiol. 2015;39(4):497–504. doi: 10.1016/j.canep.2015.04.007.
  • Goldenberg D, Mackley H, Koch W, et al. Age and stage as determinants of treatment for oral cavity and oropharyngeal cancers in the elderly. Oral Oncol. 2014;50(10):976–982. doi: 10.1016/j.oraloncology.2014.07.008.
  • Kuhnt T, Stang A, Wienke A, et al. Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. Radiat Oncol. 2016;11(1):101. doi: 10.1186/s13014-016-0679-6.
  • Raguse JD, Hossamo J, Tinhofer I, et al. Patient and treatment-related risk factors for osteoradionecrosis of the jaw in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121(3):215–221. doi: 10.1016/j.oooo.2015.10.006.
  • Kluth EV, Jain PR, Stuchell RN, et al. A study of factors contributing to the development of osteoradionecrosis of the jaws. J Prosthet Dent. 1988;59(2):194–201. doi: 10.1016/0022-3913(88)90015-7.
  • Katsura K, Sasai K, Sato K, et al. Relationship between oral health status and development of osteoradionecrosis of the mandible: a retrospective longitudinal study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(6):731–738. doi: 10.1016/j.tripleo.­2007.10.011.